Proactiv Medication Hub - Page 2
Narcolepsy: Understanding Daytime Sleepiness and Stimulant Treatment Options
Narcolepsy causes uncontrollable daytime sleepiness, often misdiagnosed as laziness. Stimulants like modafinil and armodafinil are first-line treatments to improve alertness, with newer options offering alternatives for those who don't respond. Learn how treatment works and what to expect.
MoreREMS Programs: Understanding FDA’s Risk Evaluation and Mitigation Strategies for High-Risk Medications
REMS programs are FDA-mandated safety systems for high-risk medications that require extra controls like prescriber certification, patient registries, and lab monitoring. Learn how they work, why they cause delays, and what’s changing to improve access.
MoreFeverfew and Anticoagulants: What You Need to Know About Bleeding Risk
Feverfew may help with migraines, but if you're on blood thinners, it can raise your risk of dangerous bleeding. Learn the real risks, signs to watch for, and what to do before surgery or starting anticoagulants.
MoreStimulants for ADHD: What You Need to Know About Cardiovascular and Sleep Side Effects
Stimulants for ADHD improve focus but can raise blood pressure and disrupt sleep. Learn the real risks, how to monitor them, and what alternatives exist - backed by the latest research.
MoreHypothyroidism and Statins: How to Reduce Your Myopathy Risk
Hypothyroidism increases the risk of statin-induced muscle damage. Learn how to reduce your myopathy risk by optimizing thyroid levels, choosing safer statins, and recognizing early warning signs before serious complications occur.
MoreAnnual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown
Annual savings from FDA generic drug approvals vary year to year, with billions saved when major brand-name drugs lose patent protection. Learn the real numbers behind generic cost savings and who benefits most.
MoreAnnual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown
Annual savings from FDA generic drug approvals total hundreds of billions, with major spikes when blockbuster drugs lose patent protection. Year-by-year data shows how generic competition cuts drug costs across Medicare, Medicaid, and private insurance.
MoreMedicare Part D Drug Coverage Explained for Patients in 2025
Medicare Part D in 2025 now caps out-of-pocket drug costs at $2,000 annually, eliminating the donut hole. Learn how the new three-phase coverage works, how to pick the best plan for your meds, and how to avoid costly mistakes.
MoreBiologic Drugs: Why They Can't Be Copied Like Regular Pills
Biologic drugs are made from living cells, not chemicals, so they can't be copied like regular pills. Biosimilars offer similar benefits but aren't exact copies-and that's by design.
MoreHow Pharmacogenetic Testing Prevents Dangerous Drug Reactions
Pharmacogenetic testing uses your DNA to predict how you'll respond to medications, helping doctors avoid dangerous side effects. Studies show it reduces adverse drug reactions by up to 30%.
More